Pfizer shares sink after weak 2024 forecasts
Pfizer on Wednesday forecast 2024 revenue and profit below Wall Street expectations, sending its shares down 7% in premarket trading even as it raised cost-cut target by $500 million. A drop in annual COVID vaccination rates and demand for the treatments in 2023 have dragged sales of Pfizer's…
#pfizer #sandwich #chrisboshoff